Iron intake and the risk of type 2 diabetes in women: A prospective cohort study

Diabetes Care

Volumn 29, Issue 6, 2006, Pages 1370-1376

  Rajpathak, Swapnil ^a,d   Ma, Jing ^b   Manson, JoAnn ^a,b,c   Willett, Walter C ^a,b   Hu, Frank B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ANIMAL PRODUCT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IRON INTAKE; LEAN BODY WEIGHT; LIFESTYLE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IRON; MIDDLE AGED; RISK FACTORS; UNITED STATES;

EID: 33746401956     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0119     Document Type: Article

References (58)

1. Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB: Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 27:1991-1997, 2004
2. Paolisso G, Barbagallo M: Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 10:346-355, 1997
3. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB: Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 27:134-140, 2004
4. Cefalu WT, Hu FB: Role of chromium in human health and in diabetes. Diabetes Care 27:2741-2751, 2004
5. Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willett WC, Hu FB: Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 27:2211-2216, 2004
6. Sanchez M, de la Sierra A, Coca A, Poch E, Giner V, Urbano-Marquez A: Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension 29:531-536, 1997
7. Fernandez-Real JM, Lopez-Bermejo A, Ricart W: Cross-talk between iron metabolism and diabetes. Diabetes 51:2348-2354, 2002
8. Opara EC: Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control. J Investig Med 52:19-23, 2004
9. Ramakrishnan U, Kuklina E, Stein AD: Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am J Clin Nutr 76:1256-1260, 2002
10. Sheu WH, Chen YT, Lee WJ, Wang CW, Lin LY: A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men. Clin Endocrinol (Oxf) 58:380-385, 2003
11. Tuomainen TP, Nyyssonen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA, Salonen JT: Body iron stores are associated with serum insulin and blood glucose concentrations: population study in 1,013 eastern Finnish men. Diabetes Care 20:426-428, 1997
12. Hua NW, Stoohs RA, Facchini FS: Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians. Br J Nutr 86:515-519, 2001
13. Tilbrook L: Cross talk between iron metabolism and diabetes. Ann Clin Biochem 41(Pt. 3):255, 2004
14. Piperno A, Trombini P, Gelosa M, Mauri V, Pecci V, Vergani A, Salvioni A, Mariani R, Mancia G: Increased serum ferritin is common in men with essential hypertension. J Hypertens 20:1513-1518, 2002
15. Halle M, Konig D, Berg A, Keul J, Baumstark MW: Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. Atherosclerosis 128:235-240, 1997
16. Williams MJ, Poulton R, Williams S: Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 165:179-184, 2002
17. Gillum RF: Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men: the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord 25:639-645, 2001
18. Alpert PT: New and emerging theories of cardiovascular disease: infection and elevated iron. Biol Res Nurs 6:3-10, 2004
19. Jehn M, Clark JM, Guallar E: Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 27:2422-2428, 2004
20. Lao TT, Tam KF: Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care 20:1368-1369, 1997
21. Lao TT, Chan PL, Tam KF: Gestational diabetes mellitus in the last trimester: a feature of maternal iron excess? Diabet Med 18:218-223, 2001
22. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB: Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291:711-717, 2004
23. Ford ES, Cogswell ME: Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 22:1978-1983, 1999
24. Hernandez C, Genesca J, Ignasi Esteban J, Garcia L, Simo R: Relationship between iron stores and diabetes mellitus in patients infected by hepatitis C virus: a casecontrol study. Med Clin (Barc) 115:21-22, 2000
25. Hughes K, Choo M, Kuperan P, Ong CN, Aw TC: Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore. Atherosclerosis 136:25-31, 1998
26. Thomas MC, MacIsaac RJ, Tsalamandris C, Jerums G: Elevated iron indices in patients with diabetes. Diabet Med 21:798-802, 2004
27. Kaye TB, Guay AT, Simonson DC: Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications 7:246-249, 1993
28. Jiang R, Ma J, Ascherio A, Stampfer MJ, Willett WC, Hu FB: Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. Am J Clin Nutr 79:70-75, 2004
29. Lee DH, Folsom AR, Jacobs DR Jr: Dietary iron intake and type 2 diabetes incidence in postmenopausal women: the Iowa Women's Health Study. Diabetologia 47:185-194, 2004
30. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE: Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51-65, 1985
31. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE: The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 127:188-199, 1988
32. Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML: Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc 87:43-47, 1987
33. Agricultural Research Service: USDA Nutrient Database for Standard Reference. Release 10. Washington, DC, U.S. Dept. of Agriculture, 1995
34. Willett W, Stampfer MJ: Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17-27, 1986
35. Liu JM, Hankinson SE, Stampfer MJ, Rifai N, Willett WC, Ma J: Body iron stores and their determinants in healthy postmenopausal US women. Am J Clin Nutr 78:1160-1167, 2003
36. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC: Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466-473, 1990
37. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 28:1039-1057, 1979
38. Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, Rosner B, Hennekens CH, Speizer FE: Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774-778, 1991
39. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC: Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149:531-540, 1999
40. Cox D, Oakes D: Analysis of Survival Data. London, Chapman and Hall, 1984
41. Fung TT, Schulze M, Manson JE, Willett WC, Hu FB: Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med 164:2235-2240, 2004
42. Fletcher LM, Halliday JW, Powell LW: Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J Gastroenterol Hepatol 14:202-214, 1999
43. Zijp IM, Korver O, Tijburg LB: Effect of tea and other dietary factors on iron absorption. Crit Rev Food Sci Nutr 40:371-398, 2000
44. Powell LW: Diagnosis of hemochromatosis. Semin Gastrointest Dis 13:80-88, 2002
45. Wolff SP: Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49:642-652, 1993
46. Ferrannini E: Insulin resistance, iron, and the liver. Lancet 355:2181-2182, 2000
47. Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R, Siegel E, Creutzfeldt W: Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 26:441-444, 1984
48. Wilson JG, Lindquist JH, Grambow SC, Crook ED, Maher JF: Potential role of increased iron stores in diabetes. Am J Med Sci 325:332-339, 2003
49. Fernandez-Real JM, Vendrell J, Baiget M, Gimferrer E, Ricart W: C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes. Diabetes Care 22:525-526, 1999
50. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG: Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 66:1246-1258, 2000
51. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y: A new syndrome of liver iron overload with normal transferrin saturation. Lancet 349:95-97, 1997
52. Guillygomarc'h A, Mendler MH, Moirand R, Laine F, Quentin V, David V, Brissot P, Deugnier Y: Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 35:344-349, 2001
53. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W: Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and β-cell function. Diabetes 51:1000-1004, 2002
54. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Lopez-Bermejo A, Ricart W: Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care 25:2249-2255, 2002
55. Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K: Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ 317:727, 1998
56. Cook JD: Adaptation in iron metabolism. Am J Clin Nutr 51:301-308, 1990
57. Torti SV, Torti FM: Iron and ferritin in inflammation and cancer. Adv Inorg Biochem 10:119-137, 1994
58. Monsen ER: Iron nutrition and absorption: dietary factors which impact iron bioavailability. J Am Diet Assoc 88:786-790, 1988